These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 30030022)

  • 1. Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus.
    Zhang HW; Zhao X; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):980-986. PubMed ID: 30030022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
    Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
    Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population.
    Cai A; Li G; Chen J; Li X; Li L; Zhou Y
    BMC Cardiovasc Disord; 2015 Feb; 15():14. PubMed ID: 25879827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial 8-hydroxy-2'-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus.
    Wang XB; Cui NH; Liu X; Liu X
    Cardiovasc Diabetol; 2020 Feb; 19(1):22. PubMed ID: 32075646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of elevated lipoprotein(a) on coronary artery disease phenotype and severity.
    Leistner DM; Laguna-Fernandez A; Haghikia A; Abdelwahed YS; Schatz AS; Erbay A; Roehle R; Fonseca AF; Ferber P; Landmesser U
    Eur J Prev Cardiol; 2024 May; 31(7):856-865. PubMed ID: 38348689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) and coronary artery disease in Chinese postmenopausal female patients: a large cross-sectional cohort study.
    Liu SL; Wu NQ; Guo YL; Zhu CG; Gao Y; Sun J; Xu RX; Liu G; Dong Q; Li JJ
    Postgrad Med J; 2019 Oct; 95(1128):534-540. PubMed ID: 31315919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of lipoprotein(a) and coronary artery disease in 1003 patients with stage 3-5 chronic kidney disease undergoing coronary angiography.
    Lin LH; Liu H; Tu Y; Yang Y; Wang B; Wang FM; Wu M; Pan MM; Tang RN; Ma KL; Zhang XL; Liu BC
    Coron Artery Dis; 2019 Mar; 30(2):137-142. PubMed ID: 30585793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) Is Associated with the Presence and Severity of New-Onset Coronary Artery Disease in Postmenopausal Women.
    Yan XN; Jin JL; Hong LF; Guo YL; Wu NQ; Zhu CG; Dong Q; Li JJ
    J Womens Health (Larchmt); 2020 Apr; 29(4):503-510. PubMed ID: 31905317
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correlation of lipoprotein(a) with clinical stability and severity of coronary artery lesions in patients with coronary artery disease].
    Ma Y; Rao J; Long J; Lin L; Liu J; Guo Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):235-240. PubMed ID: 30890514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease.
    Niccoli G; Cin D; Scalone G; Panebianco M; Abbolito S; Cosentino N; Jacoangeli F; Refaat H; Gallo G; Salerno G; Volpe M; Crea F; De Biase L
    Atherosclerosis; 2016 Mar; 246():214-20. PubMed ID: 26803430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein (a) is not significantly associated with type 2 diabetes mellitus: cross-sectional study of 1604 cases and 7983 controls.
    Liu C; Xu MX; He YM; Zhao X; Du XJ; Yang XJ
    Acta Diabetol; 2017 May; 54(5):443-453. PubMed ID: 28132096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum high-sensitivity C-reactive protein and lipoprotein(a) levels: a comparison between diabetic and non-diabetic patients with coronary artery disease.
    Shahid HS; Kurdi MI; Zohair AA
    Med J Malaysia; 2011 Jun; 66(2):113-6. PubMed ID: 22106689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lipoprotein(a) in predicting the severity of new on-set coronary artery disease in type 2 diabetics: A Gensini score evaluation.
    Chen J; Zhang Y; Liu J; Chen MH; Guo YL; Zhu CG; Xu RX; Dong Q; Li JJ
    Diab Vasc Dis Res; 2015 Jul; 12(4):258-64. PubMed ID: 25861813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.
    Pedreño J; Fernández R; Ballester A; Jornet A; Usón M; Canela J; Petit M
    Int J Cardiol; 2000 Jul; 74(2-3):159-67. PubMed ID: 10962116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease.
    Zhang H; Gao Y; Wu D; Zhang D
    BMC Cardiovasc Disord; 2020 Jun; 20(1):295. PubMed ID: 32546193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between lipoprotein(a) serum concentration and severity of coronary artery stenosis in an Iranian population according to Gensini score.
    Boroumand MA; Rekabi V; Davoodi G; Amirzadegan A; Saadat S; Abbasi SH; Hamidian R; Poorgholi L
    Clin Biochem; 2008 Feb; 41(3):117-20. PubMed ID: 17976374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between lipoprotein(a) and coronary artery disease, as well as its variable nature following myocardial infarction.
    Ornek E; Murat S; Duran M; Turfan M; Kurtul A; Demircelik MB; Vatankulu MA; Ocek H; Akdemir R
    Clin Invest Med; 2011 Feb; 34(1):E14-20. PubMed ID: 21291631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Lipoprotein(a) Concentration Is Associated With the Coronary Severity but Not With Events in Stable Coronary Artery Disease Patients: A Chinese Cohort Study.
    Zhou BY; Sun D; Wang C; Wu NQ; Guo YL; Zhu CG; Gao Y; Liu G; Dong Q; Li JJ
    Heart Lung Circ; 2019 Jul; 28(7):1009-1017. PubMed ID: 31178022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein(a) as a predictor for the presence and severity of premature coronary artery disease: a cross-sectional analysis of 2433 patients.
    Shi YP; Cao YX; Jin JL; Liu HH; Zhang HW; Guo YL; Gao Y; Zhu CG; Wu NQ; Li JJ
    Coron Artery Dis; 2021 Jan; 32(1):78-83. PubMed ID: 32804783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between homocysteine and lipoprotein(a) increases the prevalence of coronary artery disease/myocardial infarction in women: a case-control study.
    Balogh E; Bereczky Z; Katona E; Koszegi Z; Edes I; Muszbek L; Czuriga I
    Thromb Res; 2012 Feb; 129(2):133-8. PubMed ID: 21803402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.